Boehringer Ingelheim to Present Highly Anticipated Data From Landmark TIOSPIR …

Published September 3, 2013

Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR …
Olodaterol Respimat® has been designed to provide bronchodilatory benefits to COPD patients who need an alternative treatment option. Asthma. Further highlights from abstracts presented at ERS include Phase III data from the MezzoTinA-asthma® trials … Read more on EON: Enhanced Online News (press release)

Get nonviolent offenders out of crowded jail
These countries are not looking the other way when they see criminal activity; rather they are relying on alternative types of sanctions and are focusing on rehabilitation first, not last. Incarceration is kept as an alternative if the other … Read more on Pocono Record